Tenax Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Apr2011 Apr2012 Apr2013 Apr2014 Apr2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.10M0.36M1.19M0.26M0.05M-0.00M-0.00M-0.02M-0.02M
Cost of Revenue 0.22M0.05M0.04M0.13M
Gross Profit 0.10M0.05M0.05M-0.10M0.05M-0.00M-0.00M-0.02M-0.02M
Operating items
Research & Development 2.68M2.46M2.46M3.00M6.66M13.14M3.47M4.56M5.38M3.23M12.71M
Selling, General & Administrative 7.68M6.09M3.68M13.77M7.17M6.25M5.08M5.31M5.68M5.00M6.79M
Restructuring Costs 0.22M
Other Operating Expenses 0.30M0.03M0.03M1.03M33.27M
Operating Expenses 10.67M8.58M6.38M16.77M14.87M52.65M8.56M9.87M11.05M8.23M19.49M
Operating Income 10.56M-8.22M-5.19M-16.61M-14.82M-52.65M-8.56M-9.87M11.05M-8.23M-19.49M
EBIT 10.56M-8.22M-5.19M-16.61M-14.82M-52.65M-8.56M-9.87M11.05M-8.23M-19.49M
Non-operating items
Non Operating Investment Income -0.03M-0.11M0.00M0.00M
Interest & Investment Income 0.48M1.91M
Other Non Operating Income -0.29M-0.08M0.01M-0.72M0.78M0.76M0.16M0.02M-0.01M0.06M0.00M
Non Operating Income -0.29M-0.08M0.01M-0.72M0.78M0.76M0.16M0.02M-0.01M0.06M0.00M
Net income details
EBT 10.73M-15.63M-9.43M-18.82M-14.87M-52.65M-8.56M-9.87M11.05M-7.77M-17.60M
Tax Provisions -7.96M
Profit After Tax 10.45M-15.71M-9.42M-19.54M-14.08M-43.92M-8.39M-9.85M11.05M-7.71M-17.60M
Income from Continuing Operations 10.73M-15.63M-9.43M-18.82M-14.87M-44.69M-8.56M-9.87M11.05M-7.77M-17.60M
Consolidated Net Income 10.73M-15.63M-9.43M-18.82M-14.87M-44.69M-8.56M-9.87M11.05M-7.77M-17.60M
Income towards Parent Company 10.73M-15.63M-9.43M-18.82M-14.87M-44.69M-8.56M-9.87M11.05M-7.77M-17.60M
Preferred Dividend Payments 0.96M5.80M
Net Income towards Common Stockholders 10.73M15.71M10.37M25.35M14.08M43.92M-8.56M-9.87M11.05M-7.77M-17.60M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.03M0.30M3.97M
Shares Outstanding (Diluted Average) 23.35M1.39M1.76M9.36M
EBITDA 10.56M-8.22M-5.19M19.54M14.06M43.81M8.39M9.85M11.05M7.71M-19.49M
Tax Rate 15.12%